News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
686,477 Results
Type
Article (39455)
Company Profile (308)
Press Release (646714)
Section
Business (204859)
Career Advice (2027)
Deals (35482)
Drug Delivery (87)
Drug Development (80978)
Employer Resources (169)
FDA (16117)
Job Trends (14885)
News (345904)
Policy (32555)
Tag
Academia (2554)
Alliances (49405)
Alzheimer's disease (1222)
Approvals (16034)
Artificial intelligence (114)
Bankruptcy (354)
Best Places to Work (11511)
Biotechnology (215)
Breast cancer (106)
Cancer (898)
Cardiovascular disease (79)
Career advice (1694)
Cell therapy (198)
Clinical research (64041)
Collaboration (325)
Compensation (167)
COVID-19 (2539)
Cystic fibrosis (79)
Data (850)
Diabetes (133)
Diagnostics (6115)
Earnings (84269)
Employer resources (147)
Events (109387)
Executive appointments (242)
FDA (16559)
Funding (290)
Gene therapy (148)
GLP-1 (560)
Government (4332)
Healthcare (18714)
Infectious disease (2612)
Inflammatory bowel disease (106)
Interviews (316)
IPO (16307)
Job creations (3669)
Job search strategy (1446)
Layoffs (413)
Legal (7888)
Lung cancer (154)
Manufacturing (150)
Medical device (13158)
Medtech (13163)
Mergers & acquisitions (19188)
Metabolic disorders (358)
Neuroscience (1462)
NextGen Class of 2024 (6554)
Non-profit (4504)
Northern California (1201)
Obesity (212)
Opinion (181)
Patents (94)
People (56474)
Phase I (19879)
Phase II (28204)
Phase III (21049)
Pipeline (206)
Postmarket research (2555)
Preclinical (8456)
Radiopharmaceuticals (234)
Rare diseases (179)
Real estate (5951)
Regulatory (21505)
Research institute (2319)
Resumes & cover letters (353)
Southern California (1080)
Startups (3615)
United States (11618)
Vaccines (538)
Weight loss (157)
Date
Today (164)
Last 7 days (805)
Last 30 days (2789)
Last 365 days (35845)
2024 (30400)
2023 (40190)
2022 (51308)
2021 (55870)
2020 (54202)
2019 (46710)
2018 (35184)
2017 (32235)
2016 (31661)
2015 (37728)
2014 (31470)
2013 (26507)
2012 (28793)
2011 (29434)
2010 (27535)
Location
Africa (722)
Arizona (186)
Asia (37241)
Australia (6089)
California (2732)
Canada (1171)
China (210)
Colorado (118)
Connecticut (120)
Europe (79762)
Florida (393)
Georgia (98)
Illinois (311)
Indiana (177)
Kansas (96)
Maryland (516)
Massachusetts (2207)
Michigan (142)
Minnesota (247)
New Jersey (819)
New York (832)
North Carolina (660)
Northern California (1201)
Ohio (127)
Pennsylvania (745)
South America (1100)
Southern California (1080)
Texas (382)
Utah (79)
Washington State (322)
686,477 Results for "thrive biosciences inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Thrive Bioscience Welcomes Todd Lewis as Chief Commercial Officer
Thrive Bioscience, Inc. is pleased to announce that Todd Lewis has joined the executive management team as its Chief Commercial Officer.
May 16, 2024
·
2 min read
Press Releases
Thrive Bioscience Welcomes Christiaan Erik Engstrom as Chief Operating Officer and VP of Corporate Development and Finance
October 1, 2024
·
2 min read
Biotech Bay
X-Therma Achieves GMP Commercial Readiness with XT-Thrive®
X-Therma Inc., a biotechnology company developing a breakthrough platform for regenerative medicine and organ preservation, has achieved GMP commercial readiness with its flagship product, XT-Thrive®.
May 29, 2024
·
3 min read
Biotech Bay
X-Therma Announces XT-Thrive® Drug Master File (DMF) Accepted by U.S. Food and Drug Administration (FDA)
X-Therma Inc , announces that the Food and Drug Administration (FDA) accepted a Drug Master File (DMF) covering its product, XT-Thrive ® .
April 17, 2024
·
2 min read
Genetown
Thrive Bioscience Debuts Advanced Live Cell Imaging Software, Solving Major Problems in Cell-Based Research and MedicineThrive Bioscience Debuts Advanced Live Cell Imaging Software, Solving Major Problems in Cell-Based Research and Medicine
Thrive Bioscience Inc., a provider of innovative automated live cell imaging instruments and software, debuted its CellAssist Software Release 5.0, a new integrated suite of advanced live cell imaging capabilities in December at Cell Bio 2023, the annual meeting of the American Society for Cell Biology.
December 19, 2023
·
3 min read
Press Releases
Harmony Biosciences Holdings, Inc. Announces Pricing of Public Offering of Common Stock by Selling Shareholders
October 31, 2024
·
3 min read
Press Releases
Harmony Biosciences Holdings, Inc. Announces Commencement of Proposed Public Offering of Common Stock by Selling Shareholders
October 30, 2024
·
3 min read
Biotech Bay
Octave® Bioscience, Inc. Announces Publication in Nature Communications
Octave ® Bioscience, Inc. today announced the publication of a landmark manuscript in the prestigious journal, Nature Communications.
May 29, 2024
·
5 min read
Biotech Beach
Thrive Bioscience Debuts New Cell Imaging Capabilities That Advance Laboratory Automation
Thrive Bioscience Inc., an innovative provider of automated live cell imaging instruments and software, debuts a new integrated suite of unique and exciting capabilities that significantly advance the field of live cell imaging.
February 23, 2023
·
2 min read
Business
Xenetic Biosciences, Inc. Announces Executive Leadership Transition
Xenetic Biosciences, Inc. today announced the appointment of James Parslow, the Company’s Chief Financial Officer, as interim Chief Executive Officer, effective May 16, 2024.
May 22, 2024
·
5 min read
1 of 68,648
Next
